Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,954,945
+$3,230,297 QoQ
Shares Held
7,466
+20.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.68%
of 13F equity value
Holder Rank
#1,320
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MITCHELL MCLEOD PUGH & WILLIAMS INC holds $30,637,991 across 10 Drug Manufacturers - General names. LLY ranks #1 (29.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
7,466 | $8,954,945 | |
| 2 | JNJ |
Johnson & Johnson
|
28,718 | $7,293,509 | |
| 3 | ABBV |
AbbVie Inc.
|
20,243 | $5,093,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,603 | $3,289,985 | |
| 5 | PFE |
Pfizer Inc
|
69,337 | $1,669,634 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,456 | $1,121,054 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
8,716 | $1,101,179 | |
| 8 | AMGN |
Amgen Inc
|
2,634 | $953,824 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,954,945 | 7,466 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,724,648 | 6,224 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $6,688,808 | 6,224 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,993,542 | 5,234 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $4,142,422 | 5,314 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $4,273,258 | 5,174 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $4,020,576 | 5,208 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $5,669,130 | 6,399 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $5,965,548 | 6,589 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $5,257,453 | 6,758 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $4,244,823 | 7,282 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $3,879,152 | 7,222 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $3,433,402 | 7,321 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,558,822 | 7,451 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,879,160 | 7,870 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,595,853 | 8,028 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $2,630,802 | 8,114 | Shares | Sole | 2022-11-18 | |
| 2022-03-31 | $2,453,904 | 8,569 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $2,387,645 | 8,644 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,083,839 | 9,019 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,253,656 | 9,819 | Shares | Sole | 2021-11-08 | |
| 2021-03-31 | $1,797,021 | 9,619 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,752,390 | 10,379 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,536,299 | 10,379 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,654,770 | 10,079 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,194,240 | 8,609 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||